Referenties bij MAGMA 1-2014
Levertransplantatie bij cholangiocarcinoom, p. 13–15
1. Khan SA et al. Cholangiocarcinoma. Lancet. 2005 Oct 8;366(9493):1303–14.
2. Heimbach JK et al. Liver transplantation for unresectable perihilar cholangiocarcinoma.
Semin Liver Dis. 2004 May;24(2):201–7.
3. Gores GJ et al. Liver transplantation for perihilar cholangiocarcinoma. Dig Dis
2013;31:126–129.
4. Darwish Murad S et al. Efficacy of neoadjuvant chemoradiation, followed by liver
transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology.
2012 Jul;143(1):88–98.
Multidisciplinaire aanpak van colorectale levermetastasen, p. 18–19
1. Homayounfar K et al. Discrepancies between medical oncologists and surgeons in
assessment of resectability and indication for chemotherapy in patients with colorectal
liver metastases. Br J Surg 2014; 101: in press.
2. van der Pool AE et al. Optimizing the outcome of surgery in patients with rectal cancer
and synchronous liver metastases. Br J Surg. 2010 Mar; 97(3):383–90.
3. Neumann UP, Dejong CH. Split decision. Br J Surg. 2013 Feb; 100(3):310–2.
OPROEP Sclerocyst-trial, p. 27
1. Larssen TB, Rorvik J, Hoff SR, et al. The occurrence of asymptomatic and symptomatic
simple hepatic cysts. A prospective, hospital-based study. Clin Radiol 2005;60:1026–9.
2. Gevers TJ, Inthout J, Caroli A, et al. Young women with polycystic liver disease
respond best to somatostatin analogues: a pooled analysis of individual patient data.
Gastroenterology 2013; 145:357–65 e1–2.
3. Dietrich H, Hu K, Ruffin M, et al. Safety, tolerability, and pharmacokinetics of a single
dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I
study. Eur J Endocrinol 2012; 166:821–8.
4. Wolin EM, Hu K, Hughes G, et al. Safety, tolerability, pharmacokinetics, and
pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230)
in patients with gastroenteropancreatic neuroendocrine tumors: results from a
randomized, multicenter, open-label, phase I study. Cancer Chemother Pharmacol 2013;
72:387–95.
5. Colao A, Bronstein M, Freda P, et al. Pasireotide versus octreotide in acromegaly: a
head-to-head superiority study. J Clin Endocrinol Metab 2014: jc20132480.
CASUÏSTIEK – Pijn rechtsboven in buik bij Meckelse diverticulitis, p. 28
1. Uppal K, Tubbs RS, Matusz P et al, Meckel’s diverticulum: a review. Clin Anat. 2011;
May;24(4):416–22.
2. Park J, Wolff BG, Tollefson MK et al, Meckel Diverticulum, the Mayo clinic experience
with 1476 patients. Annals of surgery. 2005, Volume 241, Number 3.
3. Dumper J, Mckenzie S Mitchell P et al. Comlications of Meckel’s diverticula in adults.
Can J Surg 2006.
1
4. Thurley PD, Halliday KE, Somers JM et al, Radiological features of Meckel’s
diverticulum and its complications. Clinical Radiology 2009; 64, 109–118.
5. Mantas D, Kykalos S, Patsouras D et all. Small intestine diverticula: is there anything
new? World Journal of Gastrointestinal Surgery, 2011; 3:49–53.
6. Rivas H, Cacchione RN, Allen JW. Laparoscopic management of Meckel’s diverticulum
in adults. Surg Endosc 2003; 17:620.
CASUÏSTIEK – Somatostatinoom geassocieerd met neurofibromatose type 1, p. 29
1. Nesi G et al. Somatostatinoma: clinico-pathological features of three cases and literature
reviewed. J Gastroenterol Hepatol. 2008; 23:521–6.
2. Bukkems S et al. A rare cause of obstructive jaundice and weight loss in Von
Recklinghausen’s disease. Neth J Med. 2010; Dec; 68(12):414–7.
3. Volker Fendrich et al. Duodenal somatostatinoma associated with Von Recklinghausen’s
disease. J Hepatobiliary Pancreat Surg 2004; 11:417–421.
4. Rastogi R et al. Intra-abdominal manifestations of von Recklinghausen's
neurofibromatosis. Saudi J Gastroenterol 2008; Apr; 14(2):80–2.
5. Relles et al. Periampullary and Duodenal Neoplasms in Neurofibromatosis Type 1:
Two Cases and an Updated 20-Year Review of the Literature Yielding 76 Cases.
J Gastrointest Surg 2010; 14:1052–1061.
6. Patil S et al. Neoplasms associated with germline and somatic NF1 gene mutations.
Oncologist 2012; 17(1):101–16.
2